User banner image
User avatar
  • admin

Posts

MicroAire appoints Remco Maljers as Head of International Sales

CHARLOTTESVILLE, Va., Jan. 14, 2025 /PRNewswire/ — MicroAire Surgical Instruments, a Marmon Holdings | Berkshire Hathaway company focused on plastic and upper extremity surgery, is...

ArsenalBio and Bristol Myers Squibb Achieve Milestone for AB-4000 Series as Part of Ongoing Multi-Program Collaboration to Advance Next-Generation T Cell Therapies for Solid Tumors

— Bristol Myers Squibb exercises an exclusive license option for ArsenalBio’s AB-4000 series programs — — ArsenalBio is eligible for additional milestone payments and royalties...

Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2024 Revenue

 Preliminary, unaudited revenue for the full year 2024 of approximately $174 million Presenting at the 43rd Annual J.P. Morgan Healthcare Conference on Thursday, January 16th,...

Avacta Appoints Brian Hahn as Chief Financial Officer

Brian brings 25 years’ senior financial and operational experience, including leading GlycoMimetics’ Nasdaq IPO and financial operations LONDON and PHILADELPHIA, Jan. 13, 2025 (GLOBE NEWSWIRE)...

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America

George Medicines signs exclusive licensing agreement with Bausch Health to commercialize GMRx2 in Canada, Mexico, Columbia and Central America Bausch Health gains exclusive rights to...

Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer

Amphista Therapeutics appoints Paul Medeiros as Chief Business Officer Appointment supports the Company’s ambitions to advance its portfolio of next generation Targeted Glue™ protein degrader...

New Megatrends Report Unveils the Forces Shaping Consumer Behavior in Japan

Businesses harness megatrends to renovate, innovate and disrupt. Busy lifestyles make digital innovations and convenience a priority. Dublin, Jan. 13, 2025 (GLOBE NEWSWIRE) — The...

CBC Group’s R-Bridge Announces US$40M Synthetic Royalty-Backed Financing for Mirxes to Advance Global Expansion

–  R-Bridge will provide bespoke financing of US$40 million with a synthetic royalty structure and flexible repayment terms –  Financing will accelerate Mirxes, Singapore-based miRNA tech company’s innovation and commercialization of cancer early detection solutions in new markets –  Transaction underscores R-Bridge’s commitment to advancing life sciences innovations and expanding access to...

Creality Debuts Creality Hi and Introduces Trade-in for K2 Plus Combo at CES 2025

LAS VEGAS, Jan. 13, 2025 /PRNewswire/ — Creality, a global leader in 3D printing, showcased its latest innovations at the Consumer Electronics Show (CES) 2025,...

ADP Research: Only 24% of Global Workers Are Confident They Have Skills for Career Advancement

Study examines the untapped potential of workers in the first of a series of studies comprising the refreshed “People at Work 2025” report, built on...